Cravatex Limited has submitted a regulatory disclosure to BSE Limited regarding an upcoming board meeting. The disclosure is made under Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A meeting of the Board of Directors of the company is scheduled to be held on Wednesday, 12th August, 2026. The primary agenda of this meeting is to consider and approve the unaudited financial results for the quarter ended 30th June, 2026. The board will review both standalone and consolidated financial results.
The disclosure was signed by Sudhanshu Namdeo, who holds the positions of Company Secretary and Compliance Officer at Cravatex Limited. The document was digitally signed on 4th August, 2026 at 11:44:36 IST.
The company requested BSE Limited to take this information on record as part of their listing compliance obligations.